Retham Technologies, Inc.

Overview

Retham Technologies seeks to revolutionize the diagnosis of Heparin induced thrombocytopenia (HIT) by enabling rapid and accurate HIT testing

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. In-Vitro Diagnostic Substance Manufacturing325413

Capabilities